| | | | | | | |
 | REGENERON PHARMACEUTICALS, INC. | -0.92% | 9.06% | 13.56% | 17.31% | 82.27% | 87 446 |
 | VERTEX PHARMACEUTICALS | 0.32% | 5.50% | 8.82% | 21.81% | 44.65% | 80 788 |
 | WUXI APPTEC CO., LTD. | -1.33% | -0.17% | -1.06% | -28.30% | 44.30% | 34 168 |
 | BIONTECH SE | -0.02% | -8.01% | -18.14% | -28.67% | 123.58% | 29 635 |
 | GENMAB A/S | 0.70% | 2.61% | -11.80% | 9.45% | 103.77% | 24 611 |
 | BEIGENE, LTD. | 0.81% | 2.83% | 0.82% | 6.85% | 76.67% | 23 148 |
 | ARGENX SE | 2.13% | 3.54% | -1.03% | 24.76% | 190.15% | 20 751 |
 | SAREPTA THERAPEUTICS, INC. | 1.99% | 5.77% | 5.39% | 73.48% | 44.60% | 12 015 |
 | NEUROCRINE BIOSCIENCES, INC. | 0.72% | 2.05% | -18.70% | 4.57% | 9.67% | 9 379 |
 | LEGEND BIOTECH CORPORATION | 2.84% | 10.26% | -3.57% | 30.04% | --.--% | 8 059 |
 | KARUNA THERAPEUTICS, INC. | 0.32% | 6.58% | -8.08% | 44.94% | 155.08% | 6 751 |
 | EXELIXIS, INC. | 2.24% | 4.81% | 19.64% | -12.73% | 11.38% | 6 219 |
 | ASCENDIS PHARMA A/S | 0.79% | 4.77% | -9.45% | -7.38% | -2.49% | 6 216 |
 | INTRA-CELLULAR THERAPIES, INC. | 2.26% | 24.95% | 7.69% | -8.21% | 260.24% | 5 430 |
 | HALOZYME THERAPEUTICS, INC. | 4.60% | 16.22% | -32.88% | -5.28% | 118.23% | 5 172 |
| | | | | | | |
| Moyenne | 1.16% | 6.05% | -3.25% | 9.51% | 90.15% | |
| Moyenne pondérée par Capi. | 0.25% | 4.70% | 2.15% | 10.11% | 79.62% | |